Pseudomonas aeruginosa Community-Onset Bloodstream Infections: Characterization, Diagnostic Predictors, and Predictive Score Development-Results from the PRO-BAC Cohort
Ver/ Abrir
Registro completo
Mostrar el registro completo DCAutoría
Martínez Pérez-Crespo, Pedro María; Rojas, Álvaro; Lanz-García, Joaquín Felipe; Retamar-Gentil, Pilar; Reguera-Iglesias, José María; Lima-Rodríguez, Olalla; Del Arco Jiménez, Alfonso; Fernández Suárez, Jonathan; Jover-Saenz, Alfredo; Goikoetxea Aguirre, Josune; León Jiménez, Eva; Cantón-Bulnes, María Luisa; Ortega Lafont, Pilar; Armiñanzas Castillo, Carlos
Fecha
2022Derechos
Attribution 4.0 International
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Publicado en
Antibiotics (Basel)
. 2022 May 24;11(6):707
Editorial
MDPI
Enlace a la publicación
Palabras clave
Pseudomonas aeruginosa
Pseudomonas aeruginosa
Bloodstream infection
Community-onset
Epidemiology
Resumen/Abstract
Abstract
Community-onset bloodstream infections (CO-BSI) caused by gram-negative bacilli are common and associated with significant mortality; those caused by Pseudomonas aeruginosa are associated with worse prognosis and higher rates of inadequateempirical antibiotic treatment. The aims of this study were to describe the characteristics of patients with CO-BSI caused by P. aeruginosa, to identify predictors, and to develop a predictive score for P. aeruginosa CO-BSI.
Materials/methods: PROBAC is a prospective cohort including patients >14 years with BSI from 26 Spanish hospitals between October 2016 and May 2017. Patients with monomicrobial P. aeruginosa CO-BSI and monomicrobial Enterobacterales CO-BSI were included. Variables of interest were collected. Independent predictors of Pseudomonas aeruginosa CO-BSI were identified by logistic regression and a prediction score was developed.
Results: A total of 78patients with P. aeruginosa CO-BSI and 2572 with Enterobacterales CO-BSI were included. Patients with P. aeruginosa had a median age of 70 years (IQR 60-79), 68.8% were male, median Charlson score was 5 (IQR 3-7), and 30-daymortality was 18.5%. Multivariate analysis identified the following predictors of CO-BSI-PA [adjusted OR (95% CI)]: male gender [1.89 (1.14-3.12)], haematological malignancy [2.45 (1.20-4.99)], obstructive uropathy [2.86 (1.13-3.02)], source of infection other than urinary tract, biliary tract or intra-abdominal [6.69 (4.10-10.92)] and healthcare-associated BSI [1.85 (1.13-3.02)]. Anindex predictive of CO-BSI-PA was developed; scores ? 3.5 showed a negative predictive value of 89% and an area under the receiver operator curve (ROC) of 0.66.
Conclusions: We did not find a good predictive score of P. aeruginosa CO-BSI due to its relatively low incidence in the overall population. Our model includes variables that are easy to collect in real clinical practice and could be useful to detect patients with very low risk of P. aeruginosa CO-BSI.
Colecciones a las que pertenece
- D22 Artículos [1093]